Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schenk

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|June 13, 2001
Lysophosphatidic acid- and Gbeta-dependent activation of Dictyostelium MAP kinase ERK2P W Schenk, S J Epskamp, M L Knetsch, et al.
Practical Laboratory Medicine|July 12, 2019
Interchangeability of sodium and chloride measurements by indirect and direct ISE assays: Stakeholders, take responsibility!Wendy Pj den Elzen, Christa M Cobbaert, M Sesmu Arbous, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|August 28, 2001
Atypical hamstrings electromyographic activity as a compensatory mechanism in anterior cruciate ligament deficiencyA L Boerboom, A L Hof, J P Halbertsma, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1Paul W Schenk, Hans Stoop, Carsten Bokemeyer, et al.
Biomaterials|August 15, 2000
Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic releaseH van de Belt, D Neut, D R Uges, et al.
Molecular Pharmacology|July 19, 2003
Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell killPaul W Schenk, Mariel Brok, Antonius W M Boersma, et al.
Therapeutic Drug Monitoring|February 23, 2012
Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individualsSandra G Heil, Marchina E van der Ende, Paul W Schenk, et al.
Journal of Occupational and Environmental Medicine|December 11, 2003
Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveysPhilip S Wang, Arne Beck, Patricia Berglund, et al.
Clinical Chemistry and Laboratory Medicine|August 14, 2016
How to define reference intervals to rule in healthy individuals for clinical trials?Wendy P J den Elzen, Joop van Gerven, Paul W Schenk, et al.
Clinical Chemistry and Laboratory Medicine|April 20, 2016
Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomaliesJeroen P H M van den Wijngaard, Jaap A Bakker, Judith M E P Gillis, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|June 13, 2001
Lysophosphatidic acid- and Gbeta-dependent activation of Dictyostelium MAP kinase ERK2P W Schenk, S J Epskamp, M L Knetsch, et al.
Practical Laboratory Medicine|July 12, 2019
Interchangeability of sodium and chloride measurements by indirect and direct ISE assays: Stakeholders, take responsibility!Wendy Pj den Elzen, Christa M Cobbaert, M Sesmu Arbous, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|August 28, 2001
Atypical hamstrings electromyographic activity as a compensatory mechanism in anterior cruciate ligament deficiencyA L Boerboom, A L Hof, J P Halbertsma, et al.
Neoplasia (New York, N.Y.)|July 17, 2004
Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1Paul W Schenk, Hans Stoop, Carsten Bokemeyer, et al.
Biomaterials|August 15, 2000
Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic releaseH van de Belt, D Neut, D R Uges, et al.
Molecular Pharmacology|July 19, 2003
Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell killPaul W Schenk, Mariel Brok, Antonius W M Boersma, et al.
Therapeutic Drug Monitoring|February 23, 2012
Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individualsSandra G Heil, Marchina E van der Ende, Paul W Schenk, et al.
Journal of Occupational and Environmental Medicine|December 11, 2003
Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveysPhilip S Wang, Arne Beck, Patricia Berglund, et al.
Clinical Chemistry and Laboratory Medicine|August 14, 2016
How to define reference intervals to rule in healthy individuals for clinical trials?Wendy P J den Elzen, Joop van Gerven, Paul W Schenk, et al.
Clinical Chemistry and Laboratory Medicine|April 20, 2016
Keeping Ebola out of the lab: a practical solution on how to analyze Ebola associated blood anomaliesJeroen P H M van den Wijngaard, Jaap A Bakker, Judith M E P Gillis, et al.
Pageof 9